Transcription of Editorial Commentary on the KDIGO Clinical …
{{id}} {{{paragraph}}}
EditorialCommentary on the KDIGO Clinical Practice Guidelinefor GlomerulonephritisNot so long ago, a paper published inKidney Internationalexplored the reasons for the paucity of high-quality clinicaltrials in glomerulonephritis (GN).1 The authors identifiedseveral factors, including the low prevalence of disease, vari-ability in Clinical presentation, variability in treatmentresponses, lack of consensus about definitions, difficulty inrecruiting patients, the high cost of randomized controlledtrials, and the lack of collaborative research efforts.
Editorial Commentary on the KDIGO Clinical Practice Guideline for Glomerulonephritis Not so long ago, a paper published in Kidney International explored the reasons for the paucity of high-quality clinical
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
KDIGO Clinical, KDIGO Clinical Practice Guideline for, KDIGO Clinical Practice Guideline for Acute Kidney, KDIGO Clinical Practice Guideline for Acute Kidney Injury, KDIGO, KDIGO Clinical Practice Guideline for Glomerulonephritis, Clinical practice, KDIGO Clinical Guidelines for Management of, Clinical